HuGE Literature Finder
Records
1
-
11
| MET?14 promotes a ligand-dependent, AKT-driven invasive growth. Life science alliance 2022 5 5 (10): . Cerqua Marina, Botti Orsola, Arigoni Maddalena, Gioelli Noemi, Serini Guido, Calogero Raffaele, Boccaccio Carla, Comoglio Paolo M, Altintas Dogus |
| c-Met expression in renal cell carcinoma with bone metastases. Journal of bone oncology 2020 10 25 100315. Silva Paiva Rita, Gomes Inês, Casimiro Sandra, Fernandes Isabel, Costa Lu |
| Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer. Cancer 2017 Aug 123 (15): 2936-2944. Tarhini Ahmad A, Rafique Imran, Floros Theofanis, Tran Phu, Gooding William E, Villaruz Liza C, Burns Timothy F, Friedland David M, Petro Daniel P, Farooqui Mariya, Gomez-Garcia Jose, Gaither-Davis Autumn, Dacic Sanja, Argiris Athanassios, Socinski Mark A, Stabile Laura P, Siegfried Jill |
| Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib. Oncotarget 2016 Aug . Rimassa Lorenza, Abbadessa Giovanni, Personeni Nicola, Porta Camillo, Borbath Ivan, Daniele Bruno, Salvagni Stefania, Van Laethem Jean-Luc, Van Vlierberghe Hans, Trojan Jörg, De Toni Enrico N, Weiss Alan, Miles Steven, Gasbarrini Antonio, Lencioni Monica, Lamar Maria E, Wang Yunxia, Shuster Dale, Schwartz Brian E, Santoro Arman |
| Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation. Molecular and clinical oncology 2015 Mar 3 (2): 329-333. Oikawa Takefumi, Ohira Tatsuo, Otani Keishi, Hagiwara Masaru, Konaka Chimori, Ikeda Norihi |
| Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes. Molecular medicine reports 2015 6 12 (3): 4250-4258. Xie Cheng-Rong, Sun Hongguang, Wang Fu-Qiang, Li Zhao, Yin Yi-Rui, Fang Qin-Liang, Sun Yu, Zhao Wen-Xiu, Zhang Sheng, Zhao Wen-Xing, Wang Xiao-Min, Yin Zhen- |
| Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer. Journal of carcinogenesis & mutagenesis 2015 1 Suppl 7 4. Yan Bin, Broek Robert Vander, Saleh Anthony D, Mehta Arpita, Van Waes Carter, Chen Zho |
| Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2011 Nov 74 (2): 293-9. Han Ji-Youn, Kim Jin Young, Lee Suk Hyung, Yoo Nam Jin, Choi Byung G |
| MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. British journal of cancer 2011 (6): 814-23. Arriola E, Cañadas I, Arumí-Uría M, Dómine M, Lopez-Vilariño J A, Arpí O, Salido M, Menéndez S, Grande E, Hirsch F R, Serrano S, Bellosillo B, Rojo F, Rovira A, Albanell |
| Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. The Journal of clinical investigation 2009 Mar 119 (3): 478-91. Ma Jihong, DeFrances Marie C, Zou Chunbin, Johnson Carla, Ferrell Robert, Zarnegar Re |
| HAI-2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti-invasive functions. International journal of cancer 2008 12 124 (8): 1811-9. Tung Edmund Kwok-Kwan, Wong Chun-Ming, Yau Tai-On, Lee Joyce Man-Fong, Ching Yick-Pang, Ng Irene Oi-L |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: